Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.

Rolleman, Edgar J; Melis, Marleen; Valkema, Roelf; Boerman, Otto C; Krenning, Eric P; de Jong, Marion

Rolleman, Edgar J; Melis, Marleen; Valkema, Roelf; Boerman, Otto C; Krenning, Eric P; de Jong, Marion.

Affiliation

Rolleman EJ; Department of Nuclear Medicine, V 220, Erasmus MC, 's Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. ejrolleman@ziggo.nl

Eur J Nucl Med Mol Imaging ; 37(5): 1018-31, 2010 May.

Article in En | MEDLINE | ID: mdl-19915842

Subject(s)

Kidney/radiation effects; Radiation Injuries/prevention & control; Receptors, Peptide/therapeutic use; Somatostatin/analogs & derivatives; Somatostatin/adverse effects; Animals; Humans; Radiotherapy Dosage; Receptors, Somatostatin/metabolism; Somatostatin/metabolism; Somatostatin/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiation Injuries / Somatostatin / Receptors, Peptide / Kidney Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Eur J Nucl Med Mol Imaging Year: 2010 Document type: Article

Fulltext

XML

PubMed Links

Search on Google